High expression of Cks1 in human non-small cell lung carcinomas

Biochemical and Biophysical Research Communications

Volumn 303, Issue 3, 2003, Pages 978-984

  Inui, Naoki ^a   Kitagawa, Kyoko ^a   Miwa, Seiichi ^a   Hattori, Takayuki ^a,b   Chida, Kingo ^a   Nakamura, Hirotoshi ^a   Kitagawa, Masatoshi ^a,b  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Cks1; NSCLC; P27Kip1; Quantitative RT PCR; Skp2

Indexed keywords

MESSENGER RNA; PROTEIN KINASE; S PHASE KINASE ASSOCIATED PROTEIN 2; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CELL CYCLE S PHASE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0344211819     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00469-8     Document Type: Article

References (31)

1. Sherr C.J., Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 9:1994;1149-1163.
2. Morgan D.O. Principles of CDK regulation. Nature. 374:1995;131-134.
3. Pagano M., Tam S.W., Theodoras A.M., Beer-Romero P., Del Sal G., Chau V., Yew P.R., Draetta G.F., Rolfe M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science. 269:1995;682-685.
4. Shirane M., Harumiya Y., Ishida N., Hirai A., Miyamoto C., Hatakeyama S., Nakayama K., Kitagawa M. Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing. J. Biol. Chem. 274:1999;13886-13893.
5. Hershko A. Roles of ubiquitin-mediated proteolysis in cell cycle control. Curr. Opin. Cell Biol. 9:1997;788-799.
6. Hatakeyama S., Kitagawa M., Nakayama K., Shirane M., Matsumoto M., Hattori K., Higashi H., Nakano H., Okumura K., Onoe K., Good R.A., Nakayama K.-i. Ubiquitin-dependent degradation of IκBα is mediated by a ubiquitin ligase Skp1/Cul1/F-box protein FWD1. Proc. Natl. Acad. Sci. USA. 96:1999;3859-3863.
7. Yaron A., Davis M., Lavon I., Amit S., Manning A.M., Andersen J.S., Mann M., Mercurio F., Ben-Neriah Y. Identification of the receptor component of the IκBα-ubiquitin ligase. Nature. 396:1998;590-594.
8. Kitagawa M., Hatakeyama S., Shirane M., Matsumoto M., Ishida N., Hattori K., Nakamichi I., Kikuchi A., Nakayama K.-i., Nakayama K. An F-box protein FWD1 mediates ubiquitin-dependent ploteolysis of β-catenin. EMBO J. 18:1999;2401-2410.
9. Carrano A.C., Eytan E., Hershko A., Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1:1999;193-199.
10. Koepp D.M., Schaefer L.K., Ye X., Keyomarsi K., Chu C., Harper J.W., Elledge S.J. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science. 294:2001;173-177.
11. Tsvetkov L.M., Yeh K.H., Lee S.J., Sun H., Zhang H. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr. Biol. 9:1999;661-664.
12. Sutterluty H., Chatelain E., Mart A., Wirbelauer i.C., Senften M., Muller U., Krek W. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat. Cell Biol. 1:1999;207-214.
13. Tang Y., Reed S.I. The Cdk-associated protein Cks1 functions both in G1 and G2 in Saccharomyces cerevisiae. Genes Dev. 7:1993;822-832.
14. Bartek J., Lukas J. p27 destruction: Cks1 pulls the trigger. Nat. Cell Biol. 3:2001;E95-98.
15. Harper J.W. Protein destruction: adapting roles for Cks proteins. Curr. Biol. 11:2001;R431-435.
16. Ganoth D., Bornstein G., Ko T.K., Larsen B., Tyers M., Pagano M., Hershko A. The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27. Nat. Cell Biol. 3:2001;321-324.
17. Kip1, polyploidy, and centrosome overdeplication. EMBO J. 19:2000;2069-2081.
18. Spruck C., Strohmaier H., Watson M., Smith A.P., Ryan A., Krek T.W., Reed S.I. A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1. Mol. Cell. 7:2001;639-650.
19. Loda M., Cukorm B., Tam S.W., Lavin P., Fiorentino M., Draetta G.F., Jessup J.M., Pagano M. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med. 3:1997;231-234.
20. Catzavelos C., Bhattacharya N., Ung Y.C., Wilson J.A., Roncari L., Sandhu C., Shaw P., Yeger H., Morava-Protzner I., Kapusta L., Franssen E., Pritchard K.I., Slingerland J.M. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nat. Med. 3:1997;227-230.
21. Mori M., Mimori K., Shiraishi T., Tanaka S., Ueo H., Sugimachi K., Akiyoshi T. p27 expression and gastric carcinoma. Nat. Med. 3:1997;593.
22. Kawana H., Tamaru J., Tanaka T., Hirai A., Saito Y., Kitagawa M., Mikata A., Harigaya K., Kuriyama T. Role of p27Kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer. Am. J. Pathol. 153:1998;505-513.
23. Gstaiger M., Jordan R., Lim M., Catzavelos C., Mestan J., Slingerland J., Krek W. Skp2 is oncogenic and overexpressed in human cancers. Proc. Natl. Acad. Sci. USA. 98:2001;5043-5048.
24. Kudo Y., Kitajima S., Sato S., Miyauchi M., Ogawa I., Takata T. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res. 61:2001;7044-7047.
25. Hershko D., Bornstein G., Ben-Izhak O., Carrano A., Pagano M., Kranz M.M., Hershko A. Inverse relation between levels of p27Kip1 and of its ubiquitin ligase subunit SKp2 in colorectal carcinomas. Cancer. 91:2001;1745-1751.
26. Muller-Tidow C., Metzger R., Kugler K., Diederichs S., Idos G., Thomas M., Dockhorn-Dworniczak B., Schneider P.M., Koeffler H.P., Berdel W.E., Serve H. Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer. Cancer Res. 61:2001;647-653.
27. Ishihara S., Minato K., Hoshino H., Saito R., Hara F., Nakajima T., Mori M. The cyclin-dependent kinase inhibitor p27 as a prognostic factor in advanced non-small cell lung cancer: its immunohistochemical evaluation using biopsy specimens. Lung Cancer. 26:1999;187-194.
28. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res. 6:1996;986-993.
29. Gibson U.E., Heid C.A., Williams P.M. A novel method for real time quantitative RT-PCR. Genome Res. 6:1996;995-1001.
30. Harsch M., Bendrat K., Hofmeier G., Branscheid D., Niendorf A. A new method for histological microdissection utilizing an ultrasonically oscillating needle: demonstrated by differential mRNA expression in human lung carcinoma tissue. Am. J. Pathol. 158:2001;1985-1990.
31. Chiarle R., Fan Y., Piva R., Boggino H., Skolnik J., Novero D., Palestro G., De Wolf-Peeters C., Chilosi M., Pagano M., Inghirami G. S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase. Am. J. Pathol. 160:2002;1457-1466.